ARCHIVES

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

This article is from The Cancer Letter archive.

Vol. 24 No. 14 | April 10, 1998

Download PDF Visit The Full Archive

Related Articles

Obit: John Ultmann, A Leader In Clinical Oncology.

October 27, 2000

NHGRI Director Francis Collins To Step Down.

May 30, 2008

House Appropriations Committee Approves $1.221 Bil. Budget For NCI In Fiscal 1986; NIH Gets 45.247 Bil.

October 4, 1985

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

Computer Sciences Corp. Wins NIH Information System Contract

September 20, 2002

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997